Michelle S. Ginsberg

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, M. Dror Michaelson, Bruce G. Redman et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski et al. · JAMA · 2006 · 1.2K citations

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies

Emmet Jordan, Hyunjae R. Kim, Maria E. Arcila et al. · Cancer Discovery · 2017 · 646 citations · Full text

Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring <i>MET</i> Mutations Causing Exon 14 Skipping

Paul K. Paik, Alexander Drilon, Pang‐Dian Fan et al. · Cancer Discovery · 2015 · 569 citations · Full text

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

Tumor Biology, Partial Response Rate, Medicine +14